Call for Papers on Medicinal Chemistry Technology

Medicinal chemistry technology evolves rapidly these days and new developments are continually changing the way we live and work. This is especially true in highly competitive industries such as pharmaceutical research and development and drug discovery.

In these industries, the introduction of new enabling technologies that accelerate progress, reduce cycle time, and cut costs is of high importance, says Stevan W. Djuric, Ph.D. He and his colleague Anil Vasudevan, Ph.D., in the Discovery Chemistry and Technology group at AbbVie are charged with developing technologies that will do just that.

This fall, Djuric and Vasudevan are also teaming up to serve as Guest Editors of an ACS Medicinal Chemistry Letters Special Issue that will explore the latest medicinal chemistry technology:

“Med Chem Tech: Driving Drug Development”
Submission Deadline: Feb. 15, 2018

Advances in Medicinal Chemistry Technology

Earlier this year, ACS Medicinal Chemistry Letters collaborated with Journal of Medicinal Chemistry, ACS Combinatorial Science, and Chemical Reviews to publish the Virtual Issue “Technological Advances in Medicinal Chemistry.” It consists of 26 papers published in the journals between 2013 and 2016, including six ACS Medicinal Chemistry Letters Technology Notes:

Read the entire Virtual Issue “Technological Advances in Medicinal Chemistry.”

Med Chem Tech Call for Papers

The goal of the upcoming special issue “Med Chem Tech: Driving Drug Development” is to go beyond that virtual issue and expand the literature on medicinal chemistry technology to include the most up-to-date technological innovations in medicinal chemistry and drug discovery, say Djuric and Vasudevan.

They enthusiastically invite you to submit papers on a variety of related medicinal chemistry technology topics, including, but not limited to:

  • Advances in compound design strategies
  • Computational chemistry, including improved free-energy calculations
  • The application of artificial intelligence to medicinal chemistry, including SAR development
  • Advances in fragment-based chemistry
  • Chemical biology, including approaches to targeted protein degradation and target-engagement assessment
  • Automated chemistry with robotics
  • Integrated synthesis
  • Bioassay systems

If you have questions about submitting your research to this special issue on medicinal chemistry technology, please email Stevan W. Djuric at stevan.w.djuric@abbvie.com and Anil Vasudevan at anil.vasudevan@abbvie.com.

Submit your research for inclusion in “Med Chem Tech: Driving Drug Development” by February 15, 2018.

 

If you have comments or questions for the author of this post, please e-mail: Axial@acs.org.